Press Releases

PHILADELPHIA, July 30, 2019 /PRNewswire/ -- Wills Eye Hospital's outstanding reputation for patient care is once again being acclaimed by physicians nationwide. In the 2019-2020 U.S. News & World Report Best Hospitals Rankings, board certified physicians throughout the U.S. voted Wills Eye a top center of excellence where they would refer their most

SAN JOSE, Calif., July 30, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening bacterial infections, announced today that it has entered into an option agreement with the Serum

SEATTLE and VANCOUVER, British Columbia, July 30, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will report its second quarter 2019 financial results on

LEXINGTON, Ky., July 30, 2019 /PRNewswire/ -- Anytime Fitness, the world's fastest-growing fitness franchise, recently announced plans to introduce 40 new gyms in targeted areas throu

CAMBRIDGE, England, July 30, 2019 /PRNewswire/ -- IDTechEx, expert providers of market intelligence in emerging technologies, have forecast the medical wearables market to be worth $19.7 billion by the year 2024 in their latest research. This market will be driven by

LOMBARD, Ill., July 30, 2019 /PRNewswire/ -- Curatess, a software organization focused on delivering next-generation healthcare delivery solutions, today announced that the 

VANCOUVER and HOUSTON, TX, July 30, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce that, further to the announcement made on July

NEW YORK, July 30, 2019 /PRNewswire/ -- EY announces the launch of Pointellis, a new solution that supports the provision of individualized therapies that target each cancer patient's specific treatment needs. The new EY solution is a fully connected data infrastructure that facilitates handoffs of information between unaffiliated entities such as hospitals, l

NEW YORK, July 30, 2019 /PRNewswire/ -- For the tenth consecutive year, Hospital for Special Surgery (HSS) has been ranked the No. 1 hospital in the nation for orthopedics by U.S. News & World Report "Best Hospitals 2019-2020" survey. HSS was also recognized as a leader in the field of rheumatology, maintaining the No. 3 ranking in the country. This is t

NEW YORK, July 30, 2019 /PRNewswire/ -- NewYork-Presbyterian Hospital is ranked No. 5 in the nation and No. 1 in New York, according to U.S. New